Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients
- 6 November 1993
- journal article
- Published by Elsevier in The Lancet
- Vol. 342 (8880) , 1134-1137
- https://doi.org/10.1016/0140-6736(93)92122-a
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Gene-marking to trace origin of relapse after autologous bone-marrow transplantationThe Lancet, 1993
- Rhodamine123 reveals heterogeneity within murine Lin-, Sca-1+ hemopoietic stem cells.The Journal of Experimental Medicine, 1992
- An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transferBlood, 1992
- Retrovirus-Mediated Gene Transfer as an Approach to Analyze Neuroblastoma Relapse after Autologous Bone Marrow TransplantationHuman Gene Therapy, 1992
- GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimenThe Lancet, 1991
- Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patientsBlood, 1991
- High-dose chemotherapy and autologous bone marrow transplantation in acute myeloid leukemiaBlood, 1990
- Retroviral vector-mediated transfer of the bacterial neomycin resistance gene into fetal and adult sheep and human hematopoietic progenitors in vitroBlood, 1990
- AUTOTRANSPLANTS IN LEUKAEMIAThe Lancet, 1989
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988